Monday, October 19, 2026
MiningNewsTerminal
Monday, October 19, 2026 Admin

MILI.CN ·

X1 Entertainment Announces Stock Option Grant

Share Capital & Compensation

X1 Announces Stock Options Grant

VANCOUVER, BC – June 21, 2024 – X1 Entertainment Group Inc. (CSE:XONE; OTCQX: XOEEF; FSE: QN9) (“X1” or the “Company”) is pleased to announce it has granted an aggregate of 360,000 stock options (the “Options”) to directors, officers, and consultants of the Company to purchase 360,000 common shares (the “Shares”) in the capital of the Company pursuant to the Company’s share option plan (the “Option Grant”). The Options, which vest immediately, are exercisable at an exercise price of $0.35 per Share for a period of five years from the date of grant.

The Options are being granted following the Company’s news release, dated March 4, 2024, whereby the Company announced that a total of 360,000 Options were being voluntarily surrendered by the holders thereof (the “Holders”) and cancelled by the Company (the “Cancelled Options”). The Company announced its intention to grant to the Holders replacement options with an exercise price equal to or above the market price of the Shares on the Canadian Securities Exchange (the “CSE”) in accordance with the policies of the CSE and applicable securities laws. The Option Grant is provided as consideration for the Cancelled Options and for additional professional services rendered.

About X1

X1 Entertainment Group Inc. is a public company based in Vancouver, BC whose common shares are listed on the Canadian Securities Exchange under the ticker symbol (CSE:XONE). The Company has entered into a definitive asset purchase agreement with SKRR Exploration Inc pursuant to which the Company has agreed to acquire a 100% legal and beneficial interest in thirteen (13) contiguous mineral claims totaling 4,293.213 hectares located in the Province of Saskatchewan known as the Manson Bay Property.

For more information, please contact:

Latika Prasad CEO and Director

For enquiries, please call 604-229-9445 or toll free 1-833-923-3334 or email [email protected]. www.X1Ent.com

The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.